Tuesday 15 September 2026
Evening EditionRSS

ZOTPAPER

News without the noise

ZOTPAPER
US Politics

Lawsuit Alleges EPA Fast-Tracked Toxic Datacenter Chemicals Despite Health Risks

Environmental groups challenge approvals of two photoacid generators linked to 'sudden death' and PFAS concerns

edit
By LineZotpaper
Published
Read Time3 min
Two environmental groups have sued the U.S. Environmental Protection Agency (EPA) over its approval of two chemicals used in datacenter manufacturing, claiming the fast-track process ignored evidence of severe health risks including 'sudden death,' cancer, and neurological damage. The lawsuit also raises concerns that the compounds may be PFAS 'forever chemicals,' though much of the EPA's documentation remains redacted.

The lawsuit, filed in federal court on August 26, 2026, targets the EPA's approval of two photoacid generators—compounds typically used in semiconductor production—for import and immediate use in U.S. datacenters. The plaintiffs argue that the EPA's expedited approval process violated environmental laws and failed to adequately assess the chemicals' safety.

The two compounds, which are not named in the public filing due to confidential business information claims, have been linked in laboratory studies to acute toxicity, including 'sudden death' upon exposure, as well as chronic effects such as cancer, eye corrosion, neurological damage, and reproductive harm. The lawsuit also alleges that the chemicals are likely PFAS (per- and polyfluoroalkyl substances), commonly known as 'forever chemicals,' which persist in the environment and have been associated with numerous health issues.

The EPA's approval was granted under a fast-track mechanism that allows for expedited review of new chemicals, but the plaintiffs contend that the agency relied heavily on industry-submitted data and redacted critical information, preventing a full public health assessment. The Guardian, which reported on the lawsuit, noted that the EPA did not respond to requests for comment before publication.

Industry representatives have defended the approvals, emphasizing that the chemicals are essential for the production of advanced semiconductors used in datacenters, and that the EPA's review met legal requirements. They argue that the fast-track approval is necessary to support the growing digital economy and maintain U.S. competitive advantage.

However, environmental and public health groups assert that the EPA's actions jeopardize worker safety and community health, pointing to previous instances where expedited chemical approvals led to later regulatory reversals. The lawsuit seeks to compel the EPA to conduct a full review of the chemicals' potential risks, including environmental fate and exposure pathways.

The outcome of this case could set a precedent for how the U.S. regulates new chemicals critical to emerging technologies. The plaintiffs are requesting that the court vacate the approvals and order a comprehensive evaluation. The EPA has not yet filed a response, and a hearing date has not been set.

This legal challenge highlights the tension between technological advancement and public health protection, as the demand for datacenter capacity continues to surge with the rise of artificial intelligence and cloud computing.

§

Analysis

Why This Matters

  • The lawsuit could determine whether the EPA can continue fast-tracking approval of chemicals used in critical infrastructure without full public health review, potentially setting a precedent for other emerging technologies.
  • If the chemicals are indeed PFAS, their widespread use could lead to environmental contamination. Because they are used in datacenters (which are rapidly expanding), the cumulative impact could be significant.
  • The case also underscores the growing conflict between the Biden administration's (or current administration's) push to boost domestic semiconductor and datacenter production and the need for rigorous regulatory oversight.

Sources

newspaper

Zotpaper

Articles published under the Zotpaper byline are synthesized from multiple source publications by our AI editor and reviewed by our editorial process. Each story combines reporting from credible outlets to give readers a balanced, comprehensive view.

Editorial ProcessSubscribe